The landscape of American healthcare is undergoing a structural metamorphosis. While headlines have been dominated by the high-profile collapses of health systems like Steward Health Care and Prospect Medical Holdings—fiascos that placed private equity’s (PE) aggressive acquisition model under a harsh legislative microscope—a more subtle, yet pervasive, strategy has been unfolding in the background.
A new report from the Private Equity Stakeholder Project (PESP) has pulled back the curtain on this evolving playbook: the rise of joint ventures (JVs) between massive, profit-driven private equity firms and storied nonprofit health systems. This strategy allows PE firms to bypass the reputational risks and regulatory hurdles of traditional buyouts while embedding themselves deep within the infrastructure of community care.
The Mechanism of the Joint Venture
At its core, a joint venture is a collaborative enterprise where two or more parties pool resources—capital, specialized labor, clinical assets, or operational expertise—to achieve a shared profit motive. In the context of modern healthcare, this often manifests as a PE firm partnering with a tax-exempt nonprofit hospital system to manage specific service lines, such as behavioral health, hospice, or ambulatory surgery centers.
For the nonprofit entity, these deals are often marketed as a way to inject much-needed capital into aging infrastructure or to gain access to the operational efficiencies of a larger, well-funded partner. For the PE firm, however, the incentive is strategic: they gain immediate access to the nonprofit’s established market share, patient trust, and, crucially, a regulatory environment that is often more lenient than that applied to outright acquisitions. By "partnering" rather than "purchasing," these firms can exert significant influence over clinical operations while maintaining a veneer of community-focused stewardship.
A Chronology of the Shift
The transition from direct buyouts to collaborative joint ventures did not happen overnight. It is the result of a decade-long evolution in PE investment strategy.
- 2010–2015: The Era of Direct Buyouts: Following the passage of the Affordable Care Act, PE firms aggressively acquired independent physician practices and smaller community hospitals, aiming to consolidate fragmented markets.
- 2016–2019: Regulatory Friction: As the public and regulators began to push back against the "strip and flip" model of private equity, which critics argued led to service cuts and staffing shortages, firms began looking for ways to mitigate political exposure.
- 2020–2023: The Pandemic Catalyst: The financial strain placed on nonprofit hospitals by the Covid-19 pandemic created a "perfect storm." Nonprofits were desperate for cash, and PE firms were ready to provide it in exchange for control over lucrative service lines.
- 2024–Present: The Joint Venture Boom: The PESP report identifies this as the current dominant phase, where firms like Apollo Global Management and others are using joint ventures to hold a significant portion of their healthcare portfolios.
Supporting Data: The Scale of the Shift
The PESP findings are sobering. Currently, more than 500 healthcare facilities operate under these hybrid arrangements. Given that this figure only accounts for publicly disclosed partnerships, experts believe the actual number is likely significantly higher.
The reach of these ventures spans the entire continuum of care. Hospitals, inpatient rehabilitation centers, hospice facilities, home health agencies, behavioral health clinics, and urgent care centers have all become subjects of these deals. Perhaps most concerning to market observers is that 21.4% of all private equity-owned hospitals are now managed via joint venture structures.
Case studies highlighted in the report provide a granular look at this concentration. Lifepoint Health, a subsidiary of the private equity giant Apollo Global Management, has become a poster child for this strategy. The report indicates that an staggering 61% of Lifepoint’s hospital portfolio is now structured through joint ventures with nonprofit or other community-based healthcare providers. Other major players, including Compassus, Ardent Health Services, and Ascension, have similarly integrated these models into their core operations.
Official Responses and the Regulatory Gap
The primary concern, voiced by Jim Baker, executive director of PESP, is that the regulatory frameworks governing these partnerships are woefully antiquated.
"Private equity’s healthcare playbook is evolving," Baker noted in a recent statement. "Our research documents how private equity has increasingly relied on joint ventures with nonprofits to expand its presence in healthcare. These arrangements have received far less attention than traditional private equity buyouts, even as they become more common across hospitals and other healthcare sectors."
The crux of the regulatory issue lies in the Internal Revenue Service (IRS) rules governing partnerships between tax-exempt nonprofits and for-profit entities. The current guidance dates back to 1998 and 2004—years before the rise of the modern, multibillion-dollar private equity healthcare apparatus. These rules were designed for a much simpler time, failing to account for the sophisticated, multi-layered financial structures now employed by PE firms.
"Healthcare business models don’t stand still, and oversight frameworks shouldn’t either," Baker added. "Policymakers should have a clear understanding of how these partnerships are structured, how they operate, and whether current oversight reflects the realities of private equity’s healthcare acquisition strategies."
Implications: The Long-Term Cost of Care
The shift toward joint ventures carries profound implications for the future of American medicine.
1. Erosion of the Nonprofit Mission
The original intent of the nonprofit hospital model was to provide care to the community regardless of profit margins. When a nonprofit enters a joint venture with a private equity firm, the fiduciary duty to maximize shareholder value for the PE partner often clashes with the mission of providing affordable, equitable care. This tension can lead to the prioritization of profitable procedures over essential, low-margin services like emergency care or maternity wards.
2. Lack of Transparency
One of the most alarming aspects of these joint ventures is the lack of transparency. When a private equity firm buys a hospital, it is often subject to public scrutiny and regulatory oversight. However, when a nonprofit maintains a minority stake in a venture, the financial and operational details are often obscured behind complex legal agreements, making it difficult for the public, regulators, and even the hospital’s board members to fully understand the impact on patient care.
3. Regulatory Arbitrage
By operating through joint ventures, private equity firms are effectively engaging in regulatory arbitrage. They utilize the tax-exempt status and community credibility of the nonprofit partner to shield themselves from the political backlash that often follows traditional acquisitions. This allows them to expand their footprint with minimal public resistance, creating a "shadow" healthcare system that operates outside the traditional rules of the road.
A Path Forward: Policy Recommendations
The PESP report concludes with a clarion call for reform. It suggests that if the U.S. healthcare system is to avoid further consolidation of power by private interests, several steps must be taken:
- Updated Tax Guidance: The IRS must modernize its rules for nonprofit/for-profit partnerships to ensure that tax-exempt entities are not merely acting as shells for private equity profits.
- Expanded Transaction Reviews: State and federal regulators should broaden their scope of review for hospital mergers and acquisitions to specifically include joint venture agreements.
- Ongoing Reporting Requirements: These partnerships should not be "set and forget." Mandatory, transparent reporting on the clinical and financial outcomes of these ventures should be required long after the deal has closed.
- Enhanced Board Accountability: Nonprofit boards, which often approve these deals, must be held to higher standards of fiduciary duty, ensuring they are not trading their community’s health for a short-term cash infusion.
As private equity continues to pivot its strategy, the onus falls on policymakers to catch up. The current trajectory suggests that if left unchecked, the "joint venture" will become the default mode of operation for American healthcare—a trend that could permanently alter the relationship between hospitals and the communities they serve. Without decisive action, the nonprofit hospital, once a bastion of public service, may increasingly serve as a thin veil for private profit.
